Precision Diagnostics & Medicine Market by Diagnostic Testing (Genetic, DTC), Diagnostics Indication (Oncology, Neurology, Immunology), Therapeutic Products (Inhibitors, mAbs, CGT), Indication (Oncology, Rare Disease, Infectious) - Global Forecast to 2029

Precision Diagnostics & Medicine Market by Diagnostic Testing (Genetic, DTC), Diagnostics Indication (Oncology, Neurology, Immunology), Therapeutic Products (Inhibitors, mAbs, CGT), Indication (Oncology, Rare Disease, Infectious) - Global Forecast to 2029

The global Precision Diagnostics and Medicine market is projected to reach USD 246.66 billion in 2029 from USD 145.53 billion by 2024, at a CAGR of 11.1% during the forecast period. Factors such as the ongoing integration of advanced technologies such as artificial intelligence and machine learning to enhance precision medicine development, supported by the rising collaboration and investments by major pharmaceutical and diagnostics companies to develop better precision medicine solutions are supporting the growth of the market. Moreover, the expanding focus of these companies to develop precision therapies and diagnostic tests for multiple diseases such as neurodegenerative and autoimmune diseases highlight the growing importance of precision medicine in healthcare. Additionally, the increasing awareness of patients regarding their health is supporting the adoption of wearable medical devices and direct-to-consumer precision diagnostic tests offering growth opportunities to players in this market. However, the high cost of precision healthcare and challenges associated with the integration and management of big data in healthcare are expected to restrain the growth of this market.

“The monoclonal antibodies segment registered the highest growth rate in the precision medicine market, by products, during the forecast period”

In 2023, the monoclonal antibodies segment registered the highest growth rate within the precision medicine market by products. Factors such as the increasing collaborations to develop advanced monoclonal antibodies and advancements in antibody engineering technologies are attributed to the growth of this segment. Additionally, these modalities offer various advantages over traditional drugs such as high specificity, low toxicity, and longer-lasting effects among others increasing the adoption of these drug modalities for the treatment of cancer, autoimmune, and infectious diseases supporting the growth of this segment.

“The hospitals and clinics end user segment registered the highest growth rate and largest market share in the precision medicine market, by end user, during the forecast period”

The hospitals and clinic end users registered the highest growth rate within the precision medicine market by end user segment during the forecast period. Factors such as the growing demand for personalized treatments and the ability of hospitals and clinics to offer personalized therapies in a controlled environment can be attributed to the large share of this end user segment. Moreover, the rising collaborations between hospitals and pharmaceutical and diagnostic companies to develop personalized therapies and diagnostic tests support the growth of this segment. Hospitals and clinics act as data reservoirs for these companies which gather real-world data from these institutions for the development of advanced precision solutions. This high growth is projected to continue during the forecast period.

“Asia Pacific: The fastest growing region in the Precision Diagnostics market”

The precision diagnostics market of Asia Pacific is projected to register the highest growth rate during the forecast period. This high growth is attributed to the rising cases of chronic diseases, cancer, and genetic disorders in this region leading to a growing demand for precision diagnostics solutions. This growth is supported by investments in healthcare infrastructure across countries like China, India, and Japan, enhancing access to advanced diagnostic technologies. Additionally, the adoption of technologies like next-generation sequencing (NGS), artificial intelligence, and machine learning is driving innovations in the field. Government initiatives and improved healthcare coverage also contribute to expanding access to precision diagnostics. Moreover, the support and funding from government organizations for life sciences research and development also support the rapid growth of the Asia Pacific precision diagnostics market.

The primary interviews conducted for this report can be categorized as follows:

By Company Type: Tier 1 – 44%, Tier 2 – 32%, and Tier 3 – 24%

By Designation: (Managers) - 45%, (CXOs, Directors)- 30%, and(Executives) - 25%

By Region: North America -40%, Europe -25%, Asia-Pacific -20%, ROW -15%

List of Companies Profiled in the Report:

Merck & Co., Inc. (US)

F. Hoffmann-La Roche Ltd (Switzerland)

Agilent Technologies, Inc. (US)

Thermo Fisher Scientific Inc. (US)

Myriad Genetics, Inc. (US)

Guardant Health (US)

Abbott (US)

Natera Inc. (US)

Illumina, Inc. (US)

Danaher (US)

Exact Sciences Corporation (US)

Qiagen (Netherlands)

23andME, INC. (US)

ARUP Laboratories. (US)

Devyser (Sweden)

Diasorin S.P.A. (Italy)

Tempus (US)

Pillar Biosciences Inc. (US)

Invivoscribe, Inc. (US)

NeuroCode (US)

C₂N Diagnostics (US)

Trinity Biotech Plc. (Ireland)

Amoy Diagnostics Co., Ltd. (China)

Novartis AG (Switzerland)

Bristol-Myers Squibb Company (US)

Gilead Sciences, Inc. (US)

AstraZeneca (UK)

AbbVie Inc. (US)

Eli Lilly and Company. (US)

Pfizer Inc. (US), GSK plc. (UK)

Sanofi (France)

Johnson & Johnson Services, Inc. (US)

Vertex Pharmaceuticals Incorporated (US)

Amgen Inc. (US)

Merck KGaA (Germany)

Sarepta Therapeutics, Inc. (US).

Research Coverage:

This report provides a detailed picture of the global Precision Diagnostics and Medicine Market. It aims to estimate the size and future growth potential of the market across different segments such as the precision diagnostics market (type, indication, and end user) and precision medicine market (product, indication, and end user) region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the precision diagnostics and medicine market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements, new product launches, mergers and acquisitions, and recent developments associated with the precision diagnostics and medicine market. Competitive analysis of upcoming startups in the precision diagnostics and medicine market ecosystem is covered in this report.

Reasons to buy this report :

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall precision diagnostics and medicine market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

Analysis of key drivers (Increasing Integration Of AI And ML To Improve Precision Diagnostics And Therapy Development, Rising Collaborations Between Pharmaceutical And Diagnostics Company To Enhance Precision Healthcare and Rise in direct-to-consumer testing), restraints (High costs of precision healthcare and Slow Pace Of Reimbursement For Precision Diagnostics), opportunities (Expanding The Application Of Precision Diagnostics From Oncology and Integration of wearable devices to enhance precision healthcare), and challenges (Challenges in Regulatory Approval for Diagnostics and Big Data Management and Integration) influencing the growth of the precision diagnostics and medicine market.

Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches and approvals in the precision diagnostics and medicine market

Market Development: Comprehensive information about lucrative markets – the report analyses the precision diagnostics and medicine market across varied regions.

Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the precision diagnostics and medicine market

Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players in precision diagnostics market like- F. Hoffmann-La Roche Ltd. (Switzerland), Abbott (US), Agilent Technologies, Inc. (US), Guardant Health (US), Thermo Fisher Scientific Inc. (US), Myriad Genetics, Inc. (US) among others and precision medicine market like- Merck & Co., Inc. (US), Bristol-Myers Squibb Company (US) Gilead Sciences, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), AstraZeneca (UK), Novartis AG (Switzerland), among others.

Tables List

Table 1 Precision Diagnostics And Medicine Market: Inclusions And Exclusions

Table 2 Precision Diagnostics And Medicine Market: Risk Assessment

Table 3 Precision Diagnostics And Medicine Market: Impact Analysis

Of Market Dynamics

Table 4 Average Selling Price Trend Of Precision Diagnostic Tests,

By Key Player, 2021–2023 (Usd)

Table 5 Average Selling Price Trend Of Precision Medicine Products,

By Key Player, 2021–2023 (Usd)

Table 6 Average Selling Price Trend Of Precision Medicine Products,

By Region, 2021–2023 (Usd)

Table 7 Precision Diagnostics And Medicine Market: Role Of Companies In Ecosystem

Table 8 Precision Medicine Products In Clinical Pipeline, 2025–2029

Table 9 Precision Diagnostic Tests Approved By Fda

Table 10 Precision Diagnostic Products Analysis

Table 11 Patents Filed, By Document Type, 2014–2024

Table 12 Precision Diagnostics And Medicine Market: Innovations And Patent Registrations, 2019–2024

Table 13 Import Data For Diagnostic Or Laboratory Reagents For Hs Code 382200, 2019–2023 (Usd Thousand)

Table 14 Import Data For Diagnostic Or Laboratory Reagents For Hs Code 382200, 2019–2023 (Tons)

Table 15 Export Data For Diagnostic Or Laboratory Reagents For Hs Code 382200, 2019–2023 (Usd Thousand)

Table 16 Export Data For Diagnostic Or Laboratory Reagents For Hs Code 382200, 2019–2023 (Tons)

Table 17 Precision Diagnostics And Medicine Market: Key Conferences And Events, 2025–2026

Table 18 North America: Regulatory Bodies, Government Agencies, And Other Organizations

Table 19 Europe: Regulatory Bodies, Government Agencies, And Other Organizations

Table 20 Asia Pacific: Regulatory Bodies, Government Agencies, And Other Organizations

Table 21 Latin America: Regulatory Bodies, Government Agencies, And Other Organizations

Table 22 Middle East & Africa: Regulatory Bodies, Government Agencies, And Other Organizations

Table 23 Precision Diagnostics Market: Porter’s Five Forces Analysis

Table 24 Precision Medicine Market: Porter’s Five Forces Analysis

Table 25 Influence Of Stakeholders On Buying Process Of Precision Diagnostic Products, By Type

Table 26 Influence Of Stakeholders On Buying Process Of Precision Medicine Products, By Product

Table 27 Buying Criteria For Precision Diagnostic Products, By End User

Table 28 Buying Criteria For Precision Medicine Products, By End User

Table 29 Precision Diagnostics Market, By Type, 2022–2029 (Usd Billion)

Table 30 Precision Diagnostics Market For Genetic Testing, By Region,

2022–2029 (Usd Billion)

Table 31 North America: Precision Diagnostics Market For Genetic Testing,

By Country, 2022–2029 (Usd Billion)

Table 32 Europe: Precision Diagnostics Market For Genetic Testing, By Country, 2022–2029 (Usd Billion)

Table 33 Asia Pacific: Precision Diagnostics Market For Genetic Testing,

By Country, 2022–2029 (Usd Billion)

Table 34 Latin America: Precision Diagnostics Market For Genetic Testing,

By Country, 2022–2029 (Usd Billion)

Table 35 Precision Diagnostics Market For Dtc Testing, By Region,

2022–2029 (Usd Billion)

Table 36 North America: Precision Diagnostics Market For Dtc Testing,

By Country, 2022–2029 (Usd Billion)

Table 37 Europe: Precision Diagnostics Market For Dtc Testing, By Country, 2022–2029 (Usd Billion)

Table 38 Asia Pacific: Precision Diagnostics Market For Dtc Testing, By Country, 2022–2029 (Usd Billion)

Table 39 Latin America: Precision Diagnostics Market For Dtc Testing,

By Country, 2022–2029 (Usd Billion)

Table 40 Precision Diagnostics Market For Other Types, By Region,

2022–2029 (Usd Billion)

Table 41 North America: Precision Diagnostics Market For Other Types,

By Country, 2022–2029 (Usd Billion)

Table 42 Europe: Precision Diagnostics Market For Other Types, By Country, 2022–2029 (Usd Billion)

Table 43 Asia Pacific: Precision Diagnostics Market For Other Types, By Country, 2022–2029 (Usd Billion)

Table 44 Latin America: Precision Diagnostics Market For Other Types,

By Country, 2022–2029 (Usd Billion)

Table 45 Precision Diagnostics Market, By Indication, 2022–2029 (Usd Billion)

Table 46 Precision Diagnostics Market For Oncology, By Region,

2022–2029 (Usd Billion)

Table 47 North America: Precision Diagnostics Market For Oncology,

By Country, 2022–2029 (Usd Billion)

Table 48 Europe: Precision Diagnostics Market For Oncology, By Country,

2022–2029 (Usd Billion)

Table 49 Asia Pacific: Precision Diagnostics Market For Oncology, By Country, 2022–2029 (Usd Billion)

Table 50 Latin America: Precision Diagnostics Market For Oncology, By Country, 2022–2029 (Usd Billion)

Table 51 Precision Diagnostics Market For Neurology, By Region,

2022–2029 (Usd Billion)

Table 52 North America: Precision Diagnostics Market For Neurology,

By Country, 2022–2029 (Usd Billion)

Table 53 Europe: Precision Diagnostics Market For Neurology, By Country, 2022–2029 (Usd Billion)

Table 54 Asia Pacific: Precision Diagnostics Market For Neurology, By Country, 2022–2029 (Usd Billion)

Table 55 Latin America: Precision Diagnostics Market For Neurology,

By Country, 2022–2029 (Usd Billion)

Table 56 Precision Diagnostics Market For Immunology, By Region,

2022–2029 (Usd Billion)

Table 57 North America: Precision Diagnostics Market For Immunology,

By Country, 2022–2029 (Usd Billion)

Table 58 Europe: Precision Diagnostics Market For Immunology,

By Country, 2022–2029 (Usd Billion)

Table 59 Asia Pacific: Precision Diagnostics Market For Immunology, By Country, 2022–2029 (Usd Billion)

Table 60 Latin America: Precision Diagnostics Market For Immunology,

By Country, 2022–2029 (Usd Billion)

Table 61 Precision Diagnostics Market For Other Diagnostic Indications,

By Region, 2022–2029 (Usd Billion)

Table 62 North America: Precision Diagnostics Market For Other Diagnostic Indications, By Country, 2022–2029 (Usd Billion)

Table 63 Europe: Precision Diagnostics Market For Other Diagnostic Indications, By Country, 2022–2029 (Usd Billion)

Table 64 Asia Pacific: Precision Diagnostics Market For Other Diagnostic Indications, By Country, 2022–2029 (Usd Billion)

Table 65 Latin America: Precision Diagnostics Market For Other Diagnostic Indications, By Country, 2022–2029 (Usd Billion)

Table 66 Precision Diagnostics Market, By End User, 2022–2029 (Usd Billion)

Table 67 Precision Diagnostics Market For Clinical Laboratories, By Region, 2022–2029 (Usd Billion)

Table 68 North America: Precision Diagnostics Market For Clinical Laboratories, By Country, 2022–2029 (Usd Billion)

Table 69 Europe: Precision Diagnostics Market For Clinical Laboratories,

By Country, 2022–2029 (Usd Billion)

Table 70 Asia Pacific: Precision Diagnostics Market For Clinical Laboratories,

By Country, 2022–2029 (Usd Billion)

Table 71 Latin America: Precision Diagnostics Market For Clinical Laboratories, By Country, 2022–2029 (Usd Billion)

Table 72 Precision Diagnostics Market For Hospitals, By Region,

2022–2029 (Usd Billion)

Table 73 North America: Precision Diagnostics Market For Hospitals,

By Country, 2022–2029 (Usd Billion)

Table 74 Europe: Precision Diagnostics Market For Hospitals, By Country,

2022–2029 (Usd Billion)

Table 75 Asia Pacific: Precision Diagnostics Market For Hospitals, By Country, 2022–2029 (Usd Billion)

Table 76 Latin America: Precision Diagnostics Market For Hospitals, By Country, 2022–2029 (Usd Billion)

Table 77 Precision Diagnostics Market For Home Care Settings, By Region, 2022–2029 (Usd Billion)

Table 78 North America: Precision Diagnostics Market For Home Care Settings, By Country, 2022–2029 (Usd Billion)

Table 79 Europe: Precision Diagnostics Market For Home Care Settings,

By Country, 2022–2029 (Usd Billion)

Table 80 Asia Pacific: Precision Diagnostics Market For Home Care Settings,

By Country, 2022–2029 (Usd Billion)

Table 81 Latin America: Precision Diagnostics Market For Home Care Settings, By Country, 2022–2029 (Usd Billion)

Table 82 Precision Medicine Market, By Type, 2022–2029 (Usd Billion)

Table 83 Precision Medicine Market For Monoclonal Antibodies, By Region, 2022–2029 (Usd Billion)

Table 84 North America: Precision Medicine Market For Monoclonal Antibodies, By Country, 2022–2029 (Usd Billion)

Table 85 Europe: Precision Medicine Market For Monoclonal Antibodies,

By Country, 2022–2029 (Usd Billion)

Table 86 Asia Pacific: Precision Medicine Market For Monoclonal Antibodies,

By Country, 2022–2029 (Usd Billion)

Table 87 Latin America: Precision Medicine Market For Monoclonal Antibodies, By Country, 2022–2029 (Usd Billion)

Table 88 Precision Medicine Market For Inhibitor Drugs, By Region,

2022–2029 (Usd Billion)

Table 89 North America: Precision Medicine Market For Inhibitor Drugs,

By Country, 2022–2029 (Usd Billion)

Table 90 Europe: Precision Medicine Market For Inhibitor Drugs, By Country, 2022–2029 (Usd Billion)

Table 91 Asia Pacific: Precision Medicine Market For Inhibitor Drugs,

By Country, 2022–2029 (Usd Billion)

Table 92 Latin America: Precision Medicine Market For Inhibitor Drugs,

By Country, 2022–2029 (Usd Billion)

Table 93 Precision Medicine Market For Cell & Gene Therapies, By Region,

2022–2029 (Usd Billion)

Table 94 North America: Precision Medicine Market For Cell & Gene Therapies, By Country, 2022–2029 (Usd Billion)

Table 95 Europe: Precision Medicine Market For Cell & Gene Therapies,

By Country, 2022–2029 (Usd Billion)

Table 96 Asia Pacific: Precision Medicine Market For Cell & Gene Therapies,

By Country, 2022–2029 (Usd Billion)

Table 97 Latin America: Precision Medicine Market For Cell & Gene Therapies,

By Country, 2022–2029 (Usd Billion)

Table 98 Precision Medicine Market For Antiviral & Anti-retroviral Drugs,

By Region, 2022–2029 (Usd Billion)

Table 99 North America: Precision Medicine Market For Antiviral & Anti-retroviral Drugs, By Country, 2022–2029 (Usd Billion)

Table 100 Europe: Precision Medicine Market For Antiviral & Anti-retroviral Drugs, By Country, 2022–2029 (Usd Billion)

Table 101 Asia Pacific: Precision Medicine Market For Antiviral & Anti-retroviral Drugs, By Country, 2022–2029 (Usd Billion)

Table 102 Latin America: Precision Medicine Market For Antiviral & Anti-retroviral Drugs, By Country, 2022–2029 (Usd Billion)

Table 103 Precision Medicine Market For Other Products, By Region,

2022–2029 (Usd Billion)

Table 104 North America: Precision Medicine Market For Other Products,

By Country, 2022–2029 (Usd Billion)

Table 105 Europe: Precision Medicine Market For Other Products, By Country, 2022–2029 (Usd Billion)

Table 106 Asia Pacific: Precision Medicine Market For Other Products,

By Country, 2022–2029 (Usd Billion)

Table 107 Latin America: Precision Medicine Market For Other Products,

By Country, 2022–2029 (Usd Billion)

Table 108 Precision Medicine Market, By Indication, 2022–2029 (Usd Billion)

Table 109 Precision Medicine Market For Oncology, By Region,

2022–2029 (Usd Billion)

Table 110 North America: Precision Medicine Market For Oncology, By Country, 2022–2029 (Usd Billion)

Table 111 Europe: Precision Medicine Market For Oncology, By Country,

2022–2029 (Usd Billion)

Table 112 Asia Pacific: Precision Medicine Market For Oncology, By Country, 2022–2029 (Usd Billion)

Table 113 Latin America: Precision Medicine Market For Oncology, By Country, 2022–2029 (Usd Billion)

Table 114 Precision Medicine Market For Rare Diseases, By Region,

2022–2029 (Usd Billion)

Table 115 North America: Precision Medicine Market For Rare Diseases,

By Country, 2022–2029 (Usd Billion)

Table 116 Europe: Precision Medicine Market For Rare Diseases, By Country, 2022–2029 (Usd Billion)

Table 117 Asia Pacific: Precision Medicine Market For Rare Diseases, By Country, 2022–2029 (Usd Billion)

Table 118 Latin America: Precision Medicine Market For Rare Diseases,

By Country, 2022–2029 (Usd Billion)

Table 119 Precision Medicine Market For Infectious Diseases, By Region,

2022–2029 (Usd Billion)

Table 120 North America: Precision Medicine Market For Infectious Diseases,

By Country, 2022–2029 (Usd Billion)

Table 121 Europe: Precision Medicine Market For Infectious Diseases,

By Country, 2022–2029 (Usd Billion)

Table 122 Asia Pacific: Precision Medicine Market For Infectious Diseases,

By Country, 2022–2029 (Usd Billion)

Table 123 Latin America: Precision Medicine Market For Infectious Diseases,

By Country, 2022–2029 (Usd Billion)

Table 124 Precision Medicine Market For Hematological Disorders, By Region, 2022–2029 (Usd Billion)

Table 125 North America: Precision Medicine Market For Hematological Disorders, By Country, 2022–2029 (Usd Billion)

Table 126 Europe: Precision Medicine Market For Hematological Disorders,

By Country, 2022–2029 (Usd Billion)

Table 127 Asia Pacific: Precision Medicine Market For Hematological Disorders, By Country, 2022–2029 (Usd Billion)

Table 128 Latin America: Precision Medicine Market For Hematological Disorders, By Country, 2022–2029 (Usd Billion)

Table 129 Precision Medicine Market For Other Medicine Indications, By Region, 2022–2029 (Usd Billion)

Table 130 North America: Precision Medicine Market For Other Medicine Indications, By Country, 2022–2029 (Usd Billion)

Table 131 Europe: Precision Medicine Market For Other Medicine Indications,

By Country, 2022–2029 (Usd Billion)

Table 132 Asia Pacific: Precision Medicine Market For Other Medicine Indications, By Country, 2022–2029 (Usd Billion)

Table 133 Latin America: Precision Medicine Market For Other Medicine Indications, By Country, 2022–2029 (Usd Billion)

Table 134 Precision Medicine Market, By End User, 2022–2029 (Usd Million)

Table 135 Precision Medicine Market For Hospitals & Clinics, By Region,

2022–2029 (Usd Million)

Table 136 North America: Precision Medicine Market For Hospitals & Clinics,

By Country, 2022–2029 (Usd Million)

Table 137 Europe: Precision Medicine Market For Hospitals & Clinics, By Country, 2022–2029 (Usd Million)

Table 138 Asia Pacific: Precision Medicine Market For Hospitals & Clinics,

By Country, 2022–2029 (Usd Million)

Table 139 Latin America: Precision Medicine Market For Hospitals & Clinics,

By Country, 2022–2029 (Usd Million)

Table 140 Precision Medicine Market For Home Care Settings, By Region,

2022–2029 (Usd Million)

Table 141 North America: Precision Medicine Market For Home Care Settings,

By Country, 2022–2029 (Usd Million)

Table 142 Europe: Precision Medicine Market For Home Care Settings, By Country, 2022–2029 (Usd Million)

Table 143 Asia Pacific: Precision Medicine Market For Home Care Settings,

By Country, 2022–2029 (Usd Million)

Table 144 Latin America: Precision Medicine Market For Home Care Settings,

By Country, 2022–2029 (Usd Million)

Table 145 Precision Diagnostics And Medicine Market, By Region,

2022–2029 (Usd Billion)

Table 146 North America: Precision Diagnostics Market, By Type,

2022–2029 (Usd Billion)

Table 147 North America: Precision Diagnostics Market, By Indication,

2022–2029 (Usd Billion)

Table 148 North America: Precision Diagnostics Market, By End User,

2022–2029 (Usd Billion)

Table 149 North America: Precision Medicine Market, By Product,

2022–2029 (Usd Billion)

Table 150 North America: Precision Medicine Market, By Indication,

2022–2029 (Usd Billion)

Table 151 North America: Precision Medicine Market, End User,

2022–2029 (Usd Billion)

Table 152 North America: Precision Diagnostics Market, By Country,

2022–2029 (Usd Billion)

Table 153 North America: Precision Medicine Market, By Country,

2022–2029 (Usd Billion)

Table 154 North America: Key Macroeconomic Indicators

Table 155 Us: Precision Diagnostics Market, By Type, 2022–2029 (Usd Billion)

Table 156 Us: Precision Diagnostics Market, By Indication,

2022–2029 (Usd Billion)

Table 157 Us: Precision Diagnostics Market, By End User, 2022–2029 (Usd Billion)

Table 158 Us: Precision Medicine Market, By Product, 2022–2029 (Usd Billion)

Table 159 Us: Precision Medicine Market, By Indication, 2022–2029 (Usd Billion)

Table 160 Us: Precision Medicine Market, End User, 2022–2029 (Usd Billion)

Table 161 Canada: Precision Diagnostics Market, By Type, 2022–2029 (Usd Billion)

Table 162 Canada: Precision Diagnostics Market, By Indication,

2022–2029 (Usd Billion)

Table 163 Canada: Precision Diagnostics Market, By End User,

2022–2029 (Usd Billion)

Table 164 Canada: Precision Medicine Market, By Product,

2022–2029 (Usd Billion)

Table 165 Canada: Precision Medicine Market, By Indication,

2022–2029 (Usd Billion)

Table 166 Canada: Precision Medicine Market, End User, 2022–2029 (Usd Billion)

Table 167 Europe: Precision Diagnostics Market, By Type, 2022–2029 (Usd Billion)

Table 168 Europe: Precision Diagnostics Market, By Indication,

2022–2029 (Usd Billion)

Table 169 Europe: Precision Diagnostics Market, By End User,

2022–2029 (Usd Billion)

Table 170 Europe: Precision Medicine Market, By Product,

2022–2029 (Usd Billion)

Table 171 Europe: Precision Medicine Market, By Indication,

2022–2029 (Usd Billion)

Table 172 Europe: Precision Medicine Market, By End User,

2022–2029 (Usd Billion)

Table 173 Europe: Precision Diagnostics Market, By Country,

2022–2029 (Usd Billion)

Table 174 Europe: Precision Medicine Market, By Country,

2022–2029 (Usd Billion)

Table 175 Europe: Key Macroeconomic Indicators

Table 176 Germany: Precision Diagnostics Market, By Type,

2022–2029 (Usd Billion)

Table 177 Germany: Precision Diagnostics Market, By Indication,

2022–2029 (Usd Billion)

Table 178 Germany: Precision Diagnostics Market, By End User,

2022–2029 (Usd Billion)

Table 179 Germany: Precision Medicine Market, By Product,

2022–2029 (Usd Billion)

Table 180 Germany: Precision Medicine Market, By Indication,

2022–2029 (Usd Billion)

Table 181 Germany: Precision Medicine Market, End User, 2022–2029 (Usd Billion)

Table 182 Uk: Precision Diagnostics Market, By Type, 2022–2029 (Usd Billion)

Table 183 Uk: Precision Diagnostics Market, By Indication,

2022–2029 (Usd Billion)

Table 184 Uk: Precision Diagnostics Market, By End User, 2022–2029 (Usd Billion)

Table 185 Uk: Precision Medicine Market, By Product, 2022–2029 (Usd Billion)

Table 186 Uk: Precision Medicine Market, By Indication, 2022–2029 (Usd Billion)

Table 187 Uk: Precision Medicine Market, By End User, 2022–2029 (Usd Billion)

Table 188 France: Precision Diagnostics Market, By Type, 2022–2029 (Usd Billion)

Table 189 France: Precision Diagnostics Market, By Indication,

2022–2029 (Usd Billion)

Table 190 France: Precision Diagnostics Market, By End User,

2022–2029 (Usd Billion)

Table 191 France: Precision Medicine Market, By Product, 2022–2029 (Usd Billion)

Table 192 France: Precision Medicine Market, By Indication,

2022–2029 (Usd Billion)

Table 193 France: Precision Medicine Market, End User, 2022–2029 (Usd Billion)

Table 194 Italy: Precision Diagnostics Market, By Type, 2022–2029 (Usd Billion)

Table 195 Italy: Precision Diagnostics Market, By Indication,

2022–2029 (Usd Billion)

Table 196 Italy: Precision Diagnostics Market, By End User,

2022–2029 (Usd Billion)

Table 197 Italy: Precision Medicine Market, By Product, 2022–2029 (Usd Billion)

Table 198 Italy: Precision Medicine Market, By Indication, 2022–2029 (Usd Billion)

Table 199 Italy: Precision Medicine Market, End User, 2022–2029 (Usd Billion)

Table 200 Spain: Precision Diagnostics Market, By Type, 2022–2029 (Usd Billion)

Table 201 Spain: Precision Diagnostics Market, By Indication,

2022–2029 (Usd Billion)

Table 202 Spain: Precision Diagnostics Market, By End User,

2022–2029 (Usd Billion)

Table 203 Spain: Precision Medicine Market, By Product, 2022–2029 (Usd Billion)

Table 204 Spain: Precision Medicine Market, By Indication, 2022–2029 (Usd Billion)

Table 205 Spain: Precision Medicine Market, By End User, 2022–2029 (Usd Billion)

Table 206 Rest Of Europe: Precision Diagnostics Market, By Type,

2022–2029 (Usd Billion)

Table 207 Rest Of Europe: Precision Diagnostics Market, By Indication,

2022–2029 (Usd Billion)

Table 208 Rest Of Europe: Precision Diagnostics Market, By End User,

2022–2029 (Usd Billion)

Table 209 Rest Of Europe: Precision Medicine Market, By Product,

2022–2029 (Usd Billion)

Table 210 Rest Of Europe: Precision Medicine Market, By Indication,

2022–2029 (Usd Billion)

Table 211 Rest Of Europe: Precision Medicine Market, By End User,

2022–2029 (Usd Billion)

Table 212 Asia Pacific: Precision Diagnostics Market, By Type,

2022–2029 (Usd Billion)

Table 213 Asia Pacific: Precision Diagnostics Market, By Indication,

2022–2029 (Usd Billion)

Table 214 Asia Pacific: Precision Diagnostics Market, By End User,

2022–2029 (Usd Billion)

Table 215 Asia Pacific: Precision Medicine Market, By Product,

2022–2029 (Usd Billion)

Table 216 Asia Pacific: Precision Medicine Market, By Indication,

2022–2029 (Usd Billion)

Table 217 Asia Pacific: Precision Medicine Market, End User,

2022–2029 (Usd Billion)

Table 218 Asia Pacific: Precision Diagnostics Market, By Country,

2022–2029 (Usd Billion)

Table 219 Asia Pacific: Precision Medicine Market, By Country,

2022–2029 (Usd Billion)

Table 220 Asia Pacific: Key Macroeconomic Indicators

Table 221 China: Precision Diagnostics Market, By Type, 2022–2029 (Usd Billion)

Table 222 China: Precision Diagnostics Market, By Indication,

2022–2029 (Usd Billion)

Table 223 China: Precision Diagnostics Market, By End User,

2022–2029 (Usd Billion)

Table 224 China: Precision Medicine Market, By Product, 2022–2029 (Usd Billion)

Table 225 China: Precision Medicine Market, By Indication,

2022–2029 (Usd Billion)

Table 226 China: Precision Medicine Market, By End User, 2022–2029 (Usd Billion)

Table 227 Japan: Precision Diagnostics Market, By Type, 2022–2029 (Usd Billion)

Table 228 Japan: Precision Diagnostics Market, By Indication,

2022–2029 (Usd Billion)

Table 229 Japan: Precision Diagnostics Market, By End User,

2022–2029 (Usd Billion)

Table 230 Japan: Precision Medicine Market, By Product, 2022–2029 (Usd Billion)

Table 231 Japan: Precision Medicine Market, By Indication,

2022–2029 (Usd Billion)

Table 232 Japan: Precision Medicine Market, By End User, 2022–2029 (Usd Billion)

Table 233 India: Precision Diagnostics Market, By Type, 2022–2029 (Usd Billion)

Table 234 India: Precision Diagnostics Market, By Indication,

2022–2029 (Usd Billion)

Table 235 India: Precision Diagnostics Market, By End User,

2022–2029 (Usd Billion)

Table 236 India: Precision Medicine Market, By Product, 2022–2029 (Usd Billion)

Table 237 India: Precision Medicine Market, By Indication, 2022–2029 (Usd Billion)

Table 238 India: Precision Medicine Market, By End User, 2022–2029 (Usd Billion)

Table 239 Australia: Precision Diagnostics Market, By Type,

2022–2029 (Usd Billion)

Table 240 Australia: Precision Diagnostics Market, By Indication,

2022–2029 (Usd Billion)

Table 241 Australia: Precision Diagnostics Market, By End User,

2022–2029 (Usd Billion)

Table 242 Australia: Precision Medicine Market, By Product,

2022–2029 (Usd Billion)

Table 243 Australia: Precision Medicine Market, By Indication,

2022–2029 (Usd Billion)

Table 244 Australia: Precision Medicine Market, By End User,

2022–2029 (Usd Billion)

Table 245 Rest Of Asia Pacific: Precision Diagnostics Market, By Type,

2022–2029 (Usd Billion)

Table 246 Rest Of Asia Pacific: Precision Diagnostics Market, By Indication,

2022–2029 (Usd Billion)

Table 247 Rest Of Asia Pacific: Precision Diagnostics Market, By End User,

2022–2029 (Usd Billion)

Table 248 Rest Of Asia Pacific: Precision Medicine Market, By Product,

2022–2029 (Usd Billion)

Table 249 Rest Of Asia Pacific: Precision Medicine Market, By Indication,

2022–2029 (Usd Billion)

Table 250 Rest Of Asia Pacific: Precision Medicine Market, By End User,

2022–2029 (Usd Billion)

Table 251 Latin America: Precision Diagnostics Market, By Type,

2022–2029 (Usd Billion)

Table 252 Latin America: Precision Diagnostics Market, By Indication,

2022–2029 (Usd Billion)

Table 253 Latin America: Precision Diagnostics Market, By End User,

2022–2029 (Usd Billion)

Table 254 Latin America: Precision Medicine Market, By Product,

2022–2029 (Usd Billion)

Table 255 Latin America: Precision Medicine Market, By Indication,

2022–2029 (Usd Billion)

Table 256 Latin America: Precision Medicine Market, By End User,

2022–2029 (Usd Billion)

Table 257 Latin America: Precision Diagnostics Market, By Country,

2022–2029 (Usd Billion)

Table 258 Latin America: Precision Medicine Market, By Country,

2022–2029 (Usd Billion)

Table 259 Latin America: Key Macroeconomic Indicators

Table 260 Brazil: Precision Diagnostics Market, By Type, 2022–2029 (Usd Billion)

Table 261 Brazil: Precision Diagnostics Market, By Indication,

2022–2029 (Usd Billion)

Table 262 Brazil: Precision Diagnostics Market, By End User,

2022–2029 (Usd Billion)

Table 263 Brazil: Precision Medicine Market, By Product, 2022–2029 (Usd Billion)

Table 264 Brazil: Precision Medicine Market, By Indication,

2022–2029 (Usd Billion)

Table 265 Brazil: Precision Medicine Market, By End User, 2022–2029 (Usd Billion)

Table 266 Mexico: Precision Diagnostics Market, By Type, 2022–2029 (Usd Billion)

Table 267 Mexico: Precision Diagnostics Market, By Indication,

2022–2029 (Usd Billion)

Table 268 Mexico: Precision Diagnostics Market, By End User,

2022–2029 (Usd Billion)

Table 269 Mexico: Precision Medicine Market, By Product, 2022–2029 (Usd Billion)

Table 270 Mexico: Precision Medicine Market, By Indication,

2022–2029 (Usd Billion)

Table 271 Mexico: Precision Medicine Market, By End User,

2022–2029 (Usd Billion)

Table 272 Rest Of Latin America: Precision Diagnostics Market, By Type,

2022–2029 (Usd Billion)

Table 273 Rest Of Latin America: Precision Diagnostics Market, By Indication, 2022–2029 (Usd Billion)

Table 274 Rest Of Latin America: Precision Diagnostics Market, By End User, 2022–2029 (Usd Billion)

Table 275 Rest Of Latin America: Precision Medicine Market, By Product,

2022–2029 (Usd Billion)

Table 276 Rest Of Latin America: Precision Medicine Market, By Indication,

2022–2029 (Usd Billion)

Table 277 Rest Of Latin America: Precision Medicine Market, By End User,

2022–2029 (Usd Billion)

Table 278 Middle East & Africa: Precision Diagnostics Market, By Type,

2022–2029 (Usd Billion)

Table 279 Middle East & Africa: Precision Diagnostics Market, By Indication, 2022–2029 (Usd Billion)

Table 280 Middle East & Africa: Precision Diagnostics Market, By End User,

2022–2029 (Usd Billion)

Table 281 Middle East & Africa: Precision Medicine Market, By Product,

2022–2029 (Usd Billion)

Table 282 Middle East & Africa: Precision Medicine Market, By Indication,

2022–2029 (Usd Billion)

Table 283 Middle East & Africa: Precision Medicine Market, By End User,

2022–2029 (Usd Billion)

Table 284 Middle East & Africa: Key Macroeconomic Indicators

Table 285 Overview Of Strategies Adopted By Key Players In Precision Diagnostics Market, January 2021–november 2024

Table 286 Overview Of Strategies Adopted By Key Players In Precision Medicine Market, January 2021–november 2024

Table 287 Precision Diagnostics Market: Degree Of Competition

Table 288 Precision Medicine Market: Degree Of Competition

Table 289 Precision Diagnostics Market: Region Footprint

Table 290 Precision Diagnostics Market: Type Footprint

Table 291 Precision Diagnostics Market: Indication Footprint

Table 292 Precision Medicine Market: Region Footprint

Table 293 Precision Medicine Market: Product Footprint

Table 294 Precision Medicine Market: Indication Footprint

Table 295 Precision Diagnostics Market: Detailed List Of Key Startups/Smes

Table 296 Precision Diagnostics Market: Competitive Benchmarking Of Key Startups/Smes

Table 297 Precision Medicine Market: Detailed List Of Key Startups/Smes

Table 298 Precision Medicine Market: Competitive Benchmarking Of Key Startups/Smes

Table 299 Precision Diagnostics Market: Product Launches And Approvals, January 2021–november 2024

Table 300 Precision Diagnostics Market: Deals, January 2021–november 2024

Table 301 Precision Diagnostics Market: Expansions,

January 2021–november 2024

Table 302 Precision Medicine Market: Product Launches And Approvals, January 2021–november 2024

Table 303 Precision Medicine Market: Deals, January 2021–november 2024

Table 304 Precision Medicine: Expansions, January 2021–november 2024

Table 305 F. Hoffmann-la Roche Ltd (Diagnostics): Company Overview

Table 306 F. Hoffmann-la Roche Ltd (Diagnostics): Products Offered

Table 307 F. Hoffmann-la Roche Ltd (Diagnostics): Product Launches And Approvals, January 2021–november 2024

Table 308 F. Hoffmann-la Roche Ltd (Diagnostics): Deals,

January 2021–november 2024

Table 309 Abbott: Company Overview

Table 310 Abbott: Products Offered

Table 311 Abbott: Deals, January 2021–november 2024

Table 312 Agilent Technologies, Inc.: Company Overview

Table 313 Agilent Technologies, Inc.: Products Offered

Table 314 Agilent Technologies, Inc.: Product Launches And Approvals, January 2021–november 2024

Table 315 Agilent Technologies, Inc.: Deals, January 2021–november 2024

Table 316 Agilent Technologies, Inc.: Expansions, January 2021–november 2024

Table 317 Guardant Health: Company Overview

Table 318 Guardant Health: Products Offered

Table 319 Guardant Health: Product Launches And Approvals,

January 2021–november 2024

Table 320 Guardant Health: Deals, January 2021–november 2024

Table 321 Exact Sciences Corporation: Company Overview

Table 322 Exact Sciences Corporation: Products Offered

Table 323 Exact Sciences Corporation: Product Launches And Approvals, January 2021–november 2024

Table 324 Exact Sciences Corporation: Deals, January 2021–november 2024

Table 325 Qiagen: Company Overview

Table 326 Qiagen: Products Offered

Table 327 Qiagen: Product Launches And Approvals,

January 2021–november 2024

Table 328 Qiagen: Deals, January 2021–november 2024

Table 329 Myriad Genetics, Inc.: Company Overview

Table 330 Myriad Genetics, Inc.: Products Offered

Table 331 Myriad Genetics, Inc.: Product Launches And Approvals,

January 2021–november 2024

Table 332 Myriad Genetics, Inc.: Deals, January 2021–november 2024

Table 333 Myriad Genetics, Inc.: Other Developments,

January 2021–november 2024

Table 334 Natera, Inc.: Company Overview

Table 335 Natera, Inc.: Products Offered

Table 336 Natera, Inc.: Product Launches And Approvals,

January 2021–november 2024

Table 337 Natera, Inc.: Deals, January 2021–november 2024

Table 338 Illumina, Inc.: Company Overview

Table 339 Illumina, Inc.: Products Offered

Table 340 Illumina, Inc.: Product Launches And Approvals, January 2021–november 2024

Table 341 Illumina, Inc.: Deals, January 2021–november 2024

Table 342 Thermo Fisher Scientific Inc.: Company Overview

Table 343 Thermo Fisher Scientific Inc.: Products Offered

Table 344 Thermo Fisher Scientific Inc.: Product Launches And Approvals, January 2021–november 2024

Table 345 Thermo Fisher Scientific Inc.: Deals, January 2021–november 2024

Table 346 Danaher: Company Overview

Table 347 Danaher: Products Offered

Table 348 Danaher: Product Launches And Approvals,

January 2021–november 2024

Table 349 Danaher: Deals, January 2021–november 2024

Table 350 23andme, Inc.: Company Overview

Table 351 23andme, Inc.: Products Offered

Table 352 23andme, Inc.: Deals, January 2021–november 2024

Table 353 Merck & Co., Inc.: Company Overview

Table 354 Merck & Co., Inc.: Products Offered

Table 355 Merck & Co., Inc.: Product Launches And Approvals, January 2021–december 2024

Table 356 Merck & Co., Inc.: Deals, January 2021–november 2024

Table 357 Gilead Sciences, Inc.: Company Overview

Table 358 Gilead Sciences, Inc.: Products Offered

Table 359 Gilead Sciences, Inc.: Product Launches And Approvals, January 2021–november 2024

Table 360 Gilead Sciences, Inc.: Deals, January 2021–november 2024

Table 361 F. Hoffmann-la Roche Ltd (Medicine): Company Overview

Table 362 F. Hoffmann-la Roche Ltd (Medicine): Products Offered

Table 363 F. Hoffmann-la Roche Ltd (Medicine): Product Launches And Approvals, January 2021–november 2024

Table 364 Bristol-myers Squibb Company: Company Overview

Table 365 Bristol-myers Squibb Company: Products Offered

Table 366 Bristol-myers Squibb Company: Product Launches And Approvals, January 2021–november 2024

Table 367 Bristol-myers Squibb Company: Deals, January 2021–november 2024

Table 368 Novartis Ag: Company Overview

Table 369 Novartis Ag: Products Offered

Table 370 Novartis Ag: Product Launches And Approvals,

January 2021–november 2024

Table 371 Novartis Ag: Deals, January 2021–november 2024

Table 372 Astrazeneca: Company Overview

Table 373 Astrazeneca: Products Offered

Table 374 Astrazeneca: Product Launches And Approvals, January 2021–november 2024

Table 375 Astrazeneca: Deals, January 2021–november 2024

Table 376 Abbvie Inc.: Company Overview

Table 377 Abbvie Inc.: Products Offered

Table 378 Abbvie Inc.: Product Launches And Approvals,

January 2021–november 2024

Table 379 Abbvie Inc.: Deals, January 2021–november 2024

Table 380 Abbvie Inc.: Expansions, January 2021–november 2024

Table 381 Lilly: Company Overview

Table 382 Lilly: Products Offered

Table 383 Lilly: Product Launches And Approvals, January 2021–november 2024

Table 384 Lilly: Deals, January 2021–november 2024

Table 385 Pfizer Inc.: Company Overview

Table 386 Pfizer Inc.: Products Offered

Table 387 Pfizer Inc.: Product Launches And Approvals,

January 2021–november 2024

Table 388 Pfizer Inc.: Deals, January 2021–november 2024

Table 389 Sarepta Therapeutics, Inc.: Company Overview

Table 390 Sarepta Therapeutics, Inc.: Products Offered

Table 391 Sarepta Therapeutics, Inc.: Product Launches And Approvals, January 2021–november 2024

Table 392 Sarepta Therapeutics, Inc.: Deals, January 2021–november 2024

Table 393 Vertex Pharmaceuticals Incorporated: Company Overview

Table 394 Vertex Pharmaceuticals Incorporated: Products Offered

Table 395 Vertex Pharmaceuticals Incorporated: Product Launches And Approvals, January 2021–november 2024

Table 396 Vertex Pharmaceuticals Incorporated: Deals,

January 2021–november 2024

Table 397 Gsk Plc.: Company Overview

Table 398 Gsk Plc.: Products Offered

Table 399 Gsk Plc.: Product Launches And Approvals,

January 2021–november 2024

Table 400 Gsk Plc.: Deals, January 2021–november 2024

Table 401 Sanofi: Company Overview

Table 402 Johnson & Johnson Services, Inc.: Company Overview

Table 403 Amgen Inc.: Company Overview

Table 404 Merck Kgaa: Company Overview

Table 405 Alnylam Pharmaceuticals, Inc.: Company Overview

Table 406 Incyte: Company Overview

Table 407 Arup Laboratories: Company Overview

Table 408 Devyser: Company Overview

Table 409 Diasorin S.P.A.: Company Overview

Table 410 Tempus: Company Overview

Table 411 Pillar Biosciences Inc.: Company Overview

Table 412 Invivoscribe, Inc.: Company Overview

Table 413 Neurocode: Company Overview

Table 414 C₂n Diagnostics: Company Overview

Table 415 Trinity Biotech: Company Overview

Table 416 Amoy Diagnostics Co., Ltd.: Company Overview

Figures List

Figure 1 Precision Diagnostics And Medicine Market Segmentation

Figure 2 Precision Diagnostics And Medicine Market: Research Design

Figure 3 Precision Diagnostics And Medicine Market: Breakdown Of Primary Interviews

Figure 4 Precision Diagnostics Market Size Estimation: Supply-side Analysis

Figure 5 Precision Diagnostics Market Size Estimation: Revenue Share Analysis

Figure 6 Illustrative Example Of F. Hoffmann-la Roche Ltd:

Revenue Share Analysis, 2023

Figure 7 Precision Medicine Market Size Estimation: Supply-side Analysis

Figure 8 Precision Medicine Market Size Estimation: Revenue Share Analysis

Figure 9 Illustrative Example Of Merck & Co., Inc.: Revenue Share Analysis, 2023

Figure 10 Market Size Validation From Primary Sources

Figure 11 Precision Diagnostics Market Size Estimation Methodology:

Top-down Approach

Figure 12 Precision Medicine Market Size Estimation Methodology:

Top-down Approach

Figure 13 Precision Diagnostics Market: Cagr Projections, 2024–2029

Figure 14 Precision Medicine Market: Cagr Projections, 2024–2029

Figure 15 Precision Diagnostics And Medicine Market:

Growth Analysis Of Market Dynamics

Figure 16 Precision Diagnostics And Medicine Market: Data Triangulation

Figure 17 Precision Diagnostics Market, By Type, 2024 Vs. 2029 (Usd Billion)

Figure 18 Precision Diagnostics Market, By Indication, 2024 Vs. 2029 (Usd Billion)

Figure 19 Precision Diagnostics Market, By End User, 2024 Vs. 2029 (Usd Billion)

Figure 20 Precision Medicine Market, By Product, 2024 Vs. 2029 (Usd Billion)

Figure 21 Precision Medicine Market, By Indication, 2024 Vs. 2029 (Usd Billion)

Figure 22 Precision Medicine Market, By End User, 2024 Vs. 2029 (Usd Billion)

Figure 23 Geographical Snapshot Of Precision Diagnostics Market, 2024–2029

Figure 24 Geographical Snapshot Of Precision Medicine Market, 2024–2029

Figure 25 Increasing Demand For Quick And Accurate Diagnostic Tests To Drive Precision Diagnostics Market

Figure 26 Increasing Number Of Regulatory Approvals For Personalized Medicines To Drive Precision Medicine Market

Figure 27 Genetic Testing Segment And Us Accounted For Largest Shares Of Precision Diagnostics Market In 2023

Figure 28 Oncology Segment To Have Largest Market

Share During Forecast Period

Figure 29 Home Care Settings Market Commanded Highest Share In 2023

Figure 30 Monoclonal Antibodies And Us Led North American Precision Medicine Market In 2023

Figure 31 Oncology Segment To Dominate Market During Forecast Period

Figure 32 Japan To Register Highest Growth In Precision Diagnostics Market During Forecast Period

Figure 33 Germany To Register Highest Growth In Precision Medicine Market During Forecast Period

Figure 34 Precision Diagnostics And Medicine Market: Drivers, Restraints, Opportunities, And Challenges

Figure 35 Revenue Shift And New Revenue Pockets For Players In Precision Diagnostics And Medicine Market

Figure 36 Average Selling Price Trend Of Precision Diagnostic Tests, By Key Player, 2021–2023 (Usd)

Figure 37 Average Selling Price Trend Of Precision Medicine Products,

By Key Player, 2021–2023 (Usd)

Figure 38 Average Selling Price Trend Of Precision Medicine Products,

By Region, 2021–2023 (Usd)

Figure 39 Precision Diagnostics Market: Value Chain Analysis

Figure 40 Precision Medicine Market: Value Chain Analysis

Figure 41 Precision Diagnostics Market: Supply Chain Analysis

Figure 42 Precision Medicine Market: Supply Chain Analysis

Figure 43 Precision Diagnostics And Medicine Market: Ecosystem Analysis

Figure 44 Precision Diagnostics And Medicine Market: Patent Analysis, January 2014–november 2024

Figure 45 Precision Diagnostics Market: Porter’s Five Forces Analysis

Figure 46 Precision Medicine Market: Porter’s Five Forces Analysis

Figure 47 Influence Of Stakeholders On Buying Process Of Precision Diagnostic Products, By Type

Figure 48 Influence Of Stakeholders On Buying Process Of Precision Medicine Products, By Product

Figure 49 Key Buying Criteria For Precision Diagnostic Products, By End User

Figure 50 Key Buying Criteria For Precision Medicine Products, By End User

Figure 51 North America: Precision Diagnostics And Medicine Market Snapshot

Figure 52 Europe: Precision Diagnostics And Medicine Market Snapshot

Figure 53 Precision Diagnostics Market: Revenue Analysis Of Key Players, 2021–2023 (Usd Million)

Figure 54 Precision Medicine Market: Revenue Analysis Of Key Players, 2021–2023 (Usd Million)

Figure 55 Precision Diagnostics Market Share Analysis Of Key Players, 2023

Figure 56 Precision Diagnostics Market Share Analysis Of Key Players, 2023

Figure 57 Precision Diagnostics Market: Company Evaluation Matrix (Key Players), 2023

Figure 58 Precision Diagnostics Market: Company Footprint

Figure 59 Precision Medicine Market: Company Evaluation

Matrix (Key Players), 2023

Figure 60 Precision Medicine Market: Company Footprint

Figure 61 Precision Diagnostics Market: Company Evaluation Matrix (Startups/Smes), 2023

Figure 62 Precision Medicine Market: Company Evaluation Matrix (Startups/Smes), 2023

Figure 63 Precision Diagnostics Market: Year-to-date (Ytd) Price Total Return And 5-year Stock Beta Of Key Vendors, 2024

Figure 64 Precision Diagnostics Market: Ev/Ebitda Of Key Vendors, 2024

Figure 65 Precision Medicine Market: Year-to-date (Ytd) Price Total Return And 5-year Stock Beta Of Key Vendors, 2024

Figure 66 Precision Medicine Market: Ev/Ebitda Of Key Vendors, 2024

Figure 67 Precision Diagnostics Market: Brand/Product Comparison

Figure 68 Precision Medicine Market: Brand/Product Comparison

Figure 69 F. Hoffmann-la Roche Ltd (Diagnostics): Company Snapshot (2023)

Figure 70 Abbott: Company Snapshot (2023)

Figure 71 Agilent Technologies, Inc.: Company Snapshot (2023)

Figure 72 Guardant Health: Company Snapshot (2023)

Figure 73 Exact Sciences Corporation: Company Snapshot (2023)

Figure 74 Qiagen: Company Snapshot (2023)

Figure 75 Myriad Genetics, Inc.: Company Snapshot (2023)

Figure 76 Natera, Inc.: Company Snapshot (2023)

Figure 77 Illumina, Inc.: Company Snapshot (2023)

Figure 78 Thermo Fisher Scientific Inc.: Company Snapshot (2023)

Figure 79 Danaher: Company Snapshot (2023)

Figure 80 23andme, Inc.: Company Snapshot (2023)

Figure 81 Merck & Co., Inc.: Company Snapshot (2023)

Figure 82 Gilead Sciences, Inc.: Company Snapshot (2023)

Figure 83 F. Hoffmann-la Roche Ltd (Medicine): Company Snapshot (2023)

Figure 84 Bristol-myers Squibb Company: Company Snapshot (2023)

Figure 85 Novartis Ag: Company Snapshot (2023)

Figure 86 Astrazeneca: Company Snapshot (2023)

Figure 87 Abbvie Inc.: Company Snapshot (2023)

Figure 88 Lilly: Company Snapshot (2023)

Figure 89 Pfizer Inc.: Company Snapshot (2023)

Figure 90 Sarepta Therapeutics, Inc.: Company Snapshot (2023)

Figure 91 Vertex Pharmaceuticals Incorporated: Company Snapshot (2023)

Figure 92 Gsk Plc.: Company Snapshot (2023)